NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced late Wednesday that it has priced an offering of $1.2 billion aggregate principal amount of its 2.950 percent senior notes due 2026 at the issue price of around 98.8 percent of the principal amount.

The issuance is expected to close on or about Sept. 19, and the firm said it plans to use much of the proceeds to redeem all of the outstanding $900 million aggregate principal amount of its 1.30 percent senior notes due 2017, which mature on Feb. 1, 2017. The remaining proceeds will be used for general corporate purposes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.